ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 61 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $3,000 | -50.0% | 861 | +0.8% | 0.00% | – |
| Q4 2014 | $6,000 | +20.0% | 854 | -7.3% | 0.00% | – |
| Q3 2014 | $5,000 | -50.0% | 921 | -7.8% | 0.00% | – |
| Q2 2014 | $10,000 | -16.7% | 999 | 0.0% | 0.00% | – |
| Q1 2014 | $12,000 | +9.1% | 999 | +5.9% | 0.00% | – |
| Q4 2013 | $11,000 | – | 943 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $17,037,000 | 0.97% |
| WealthTrust Axiom LLC | 140,000 | $441,000 | 0.16% |
| Palo Alto Investors LP | 1,032,715 | $3,253,000 | 0.15% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $157,000 | 0.08% |
| Joel Isaacson & Co., LLC | 80,660 | $254,000 | 0.05% |
| Malaga Cove Capital, LLC | 10,250 | $31,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $95,000 | 0.02% |
| Granahan Investment Management | 31,298 | $99,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,150 | $769,000 | 0.01% |
| Advisor Group, Inc. | 117,657 | $371,000 | 0.01% |